Uniplan Investment Counsel’s Merck MRK Stock Holding History

Uniplan Investment Counsel’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9K	Buy	+108	New	+$12.6K	﹤0.01%	175
2022 Q1	–	Sell	-44,453	Closed	-$3.41M	–	137
2021 Q4	$3.41M	Buy	+44,453	New	+$3.54M	0.19%	91
2018 Q1	–	Sell	-218,943	Closed	-$11.8M	–	123
2017 Q4	$11.8M	Sell	218,943 -17,299	-7%	-$959K	0.48%	63
2017 Q3	$14.4M	Buy	236,242 +3,097	+1%	+$188K	0.61%	51
2017 Q2	$14.3M	Buy	233,145 +7,646	+3%	+$465K	0.63%	48
2017 Q1	$13.7M	Sell	225,499 -154,886	-41%	-$9.4M	0.62%	46
2016 Q4	$12.6M	Buy	380,385 +132,186	+53%	+$7.74M	0.57%	51
2016 Q3	$14.8M	Buy	248,199 +13,437	+6%	+$786K	0.67%	46
2016 Q2	$12.9M	Sell	234,762 -31,781	-12%	-$1.69M	0.58%	49
2016 Q1	$13.5M	Sell	266,543 -779	-0.3%	-$38.2K	0.66%	49
2015 Q4	$13.5M	Sell	267,322 -67,791	-20%	-$3.42M	0.65%	52
2015 Q3	$15.8M	Sell	335,113 -41,888	-11%	-$2.23M	0.76%	48
2015 Q2	$20.5M	Buy	+377,001	New	+$21.1M	0.93%	43

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Uniplan Investment Counsel's MRK Position: Q2 2026 in Review

Uniplan Investment Counsel opened a new position in Merck (MRK) in Q2 2026: 108 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #175 among its holdings. This is a return to the name: Uniplan Investment Counsel previously reported a position in MRK as recently as Q4 2021.

Uniplan Investment Counsel first reported a position in MRK in Q2 2015 and has held it in 13 quarters since. The position peaked at $20.5M in Q2 2015. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Uniplan Investment Counsel held 108 shares of Merck worth $13.9K as of Q2 2026.
Merck was a new Uniplan Investment Counsel position in Q2 2026.
Merck made up ﹤0.01% of Uniplan Investment Counsel's portfolio in Q2 2026, its #175 holding.
Uniplan Investment Counsel first reported a position in Merck in Q2 2015 and has held it in 13 quarters since.
Uniplan Investment Counsel's Merck position peaked at $20.5M in Q2 2015.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.